Data / Form D filings / CRISPRQC INC.
CRISPRQC INC.: Form D filings
CRISPRQC INC., a biotechnology company in San Diego, CA, filed 4 Form D notices with the SEC between 2022 and 2025. The latest, on April 2, 2025, reports $3.9 million sold of a $10 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8949 KENAMAR DR, STE 101, San Diego, CA, 92121
- Phone
- (858) 444-0037
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1916528
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Amendment | $10,000,000 | $3,890,632 | $6,109,368 | 14 | Jan 2, 2024 | sec.gov |
| Feb 29, 2024 | Amendment | $10,000,000 | $944,999 | $9,055,001 | 2 | Jan 2, 2024 | sec.gov |
| Feb 27, 2024 | New notice | $10,000,000 | $900,000 | $9,100,000 | 1 | Jan 2, 2024 | sec.gov |
| Mar 22, 2022 | New notice | $4,000,000 | $885,000 | $3,115,000 | 7 | Mar 8, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ross Bundy | Executive Officer, Director | |
| George Bonaros | Director | |
| Paul Grint | Director | |
| Kiana Aran | Director | |
| Toby Richardson | Director | |
| Chris Yoo | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CRISPRQC INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.